日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes

包含沙库巴曲/缬沙坦的治疗策略对达到指南推荐血压目标和典型安全性结果的影响

Katsuya, Tomohiro; Nakatsu, Fumiko; Eguchi, Shunsuke; Nakamura, Yumiko; Matsukawa, Miyuki; Iekushi, Kazuma; Hiramitsu, Shinya

Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex

以蛋白尿减少作为日本患者IgA肾病临床研究的替代终点:来自J-CKD-DB-Ex的数据

Kashihara, Naoki; Itano, Seiji; Nakashima, Takaya; Goto, Tadahiro; Yoshihara, Keisuke; Eguchi, Shunsuke; Iekushi, Kazuma; Isaka, Yoshitaka; Nagasu, Hajime

Diagnosis and treatment in adult patients with C3 glomerulopathy in Japan: a real-world survey

日本成人C3肾小球病患者的诊断和治疗:一项真实世界调查

Nakagawa, Naoki; Kotobuki, Yutaro; Kroes, Michel; Eguchi, Shunsuke; Tsuji, Toshinaga; Simons, Alice; Libby, Susanna; Sidhu, Raisa; Smeets, Serge; Iekushi, Kazuma

Modifiable factors to achieve target blood pressure in hypertensive participants

高血压患者达到目标血压的可控因素

Tanaka-Mizuno, Sachiko; Nakatsu, Fumiko; Eguchi, Shunsuke; Iekushi, Kazuma; Nakagami, Hironori

Preferences for Injectable Lipid-Lowering Therapies in Japanese Patients with Atherosclerotic Cardiovascular Disease: Findings from a Japanese Cross-sectional Study

日本动脉粥样硬化性心血管疾病患者对注射降脂疗法的偏好:一项日本横断面研究的结果

Toda, Mitsutoshi; Iekushi, Kazuma; Takahashi, Yuri; Kohsaka, Shun

Serum Lipoprotein(a) Levels and Their Association with Atherosclerotic Cardiovascular Disease in Japan

日本血清脂蛋白(a)水平及其与动脉粥样硬化性心血管疾病的关系

Fujii, Emi; Ako, Junya; Takahashi, Yuri; Toda, Mitsutoshi; Iekushi, Kazuma; Yamashita, Shizuya

A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies

一项基于医疗索赔数据库的研究探讨了接受PCSK9单克隆抗体治疗的患者的用药依从性和治疗持续性的相关因素

Takahashi, Yuri; Morimoto, Takeshi; Iekushi, Kazuma; Arai, Hidenori

Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open-Label, Noninferiority Study (PARASOL Study).

沙库巴曲/缬沙坦与氨氯地平治疗日本原发性高血压患者的疗效和安全性:一项随机、多中心、开放标签、非劣效性研究(PARASOL 研究)

Yamamoto Koichi, Yarimizu Daisuke, Shimanishi Ayano, Eguchi Shunsuke, Iekushi Kazuma, Takami Yoichi, Nozato Yoichi, Kario Kazuomi, Rakugi Hiromi

Attitude change to secondary health examination using social nudging through a spouse

利用配偶的社会引导来改变人们对二次健康检查的态度

Katagiri, Wataru; Shimono, Masaaki; Eguchi, Shunsuke; Takebayashi, Masaki; Iekushi, Kazuma

Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study

基于夜间血压下降情况,比较沙库巴曲/缬沙坦与奥美沙坦治疗日本原发性高血压患者的24小时降压疗效:一项随机、双盲、多中心研究的事后分析

Kario, Kazuomi; Rakugi, Hiromi; Yarimizu, Daisuke; Morita, Yohei; Eguchi, Shunsuke; Iekushi, Kazuma